HowImaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy

被引：12

作者：

Farwell, Michael D. ^{[1
]}

Clark, Amy S. ^{[2
]}

Mankoff, David A. ^{[1
]}

机构：

[1] Univ Penn, Perelman Sch Med, Div Nucl Med & Mol Imaging, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA

来源：

JAMA ONCOLOGY | 2015年 / 1卷 / 04期

关键词：

POSITRON-EMISSION-TOMOGRAPHY; METASTATIC BREAST-CANCER; PREDICTS RESPONSE;

D O I：

10.1001/jamaoncol.2015.0667

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：421 / 422

页数：2

共 8 条

[1] PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer [J].

Dehdashti, Farrokh ;

Mortimer, Joanne E. ;

Trinkaus, Kathryn ;

Naughton, Michael J. ;

Ellis, Matthew ;

Katzenellenbogen, John A. ;

Welch, Michael J. ;

Siegel, Barry A. .

BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (03) :509-517

[2] Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer [J].

Dijkers, E. C. ;

Munnink, T. H. Oude ;

Kosterink, J. G. ;

Brouwers, A. H. ;

Jager, P. L. ;

de Jong, J. R. ;

van Dongen, G. A. ;

Schroder, C. P. ;

Lub-de Hooge, M. N. ;

de Vries, E. G. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (05) :586-592

[3]

Gebhart G, 2014, ASCO M ABSTRACTS S, V32, P11001

[4] Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer [J].

Linden, Hannah M. ;

Stekhova, Svetlana A. ;

Link, Jeanne M. ;

Gralow, Julie R. ;

Livingston, Robert B. ;

Ellis, Georgiana K. ;

Petra, Philip H. ;

Peterson, Lanell M. ;

Schubert, Erin K. ;

Dunnwald, Lisa K. ;

Krohn, Kenneth A. ;

Mankoff, David A. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :2793-2799

[5] Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer [J].

Linden, Hannah M. ;

Kurland, Brenda F. ;

Peterson, Lanell M. ;

Schubert, Erin K. ;

Gralow, Julie R. ;

Specht, Jennifer M. ;

Ellis, Georgiana K. ;

Lawton, Thomas J. ;

Livingston, Robert B. ;

Petra, Philip H. ;

Link, Jeanne M. ;

Krohn, Kenneth A. ;

Mankoff, David A. .

CLINICAL CANCER RESEARCH, 2011, 17 (14) :4799-4805

[6] Letter to Cancer Center Directors: Predict and/or Measure Tumor Response in Cancer Therapy Trials [J].

Mountz, James M. ;

Yankeelov, Thomas E. ;

Rubin, Daniel L. ;

Buatti, John M. ;

Erikson, Bradley J. ;

Fennessy, Fiona M. ;

Gillies, Robert J. ;

Huang, Wie ;

Jacobs, Michael A. ;

Kinahan, Paul E. ;

Laymon, Charles M. ;

Linden, Hannah M. ;

Mankoff, David A. ;

Schwartz, Lawrence H. ;

Shim, Hyunsuk ;

Wahl, Richard L. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (19) :2115-U172

[7] Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine:: A substudy of Trans-Tasman Radiation Oncology Group study 98.02 [J].

Rischin, D ;

Hicks, RJ ;

Fisher, R ;

Binns, D ;

Corry, J ;

Porceddu, S ;

Peters, LJ .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :2098-2104

[8] [18F] Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung [J].

Sohn, Hee-Jung ;

Yang, You-Jung ;

Ryu, Jin-Sook ;

Oh, Seung Jun ;

Im, Ki Chun ;

Moon, Dae Hyuk ;

Lee, Dae Ho ;

Suh, Cheolwon ;

Lee, Jung-Shin ;

Kim, Sang-We .

CLINICAL CANCER RESEARCH, 2008, 14 (22) :7423-7429

← 1 →